Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Recent increases in attention deficit hyperactivity disorder (ADHD) diagnoses, and the escalation of stimulant prescriptions, has raised concern about diversion and abuse of stimulants, as well as the ethics of using these drugs as "cognitive enhancers."Such concern appears misplaced in the face of substantial evidence that stimulant drugs do not improve the academic performance of ADHD-diagnosed students. Moreover, numerous studies have found little or no benefit of stimulants on neuropsychological tests of ADHD-diagnosed as well as normal, individuals. This paper examines the apparent paradox: why don't drugs that improve "attention," produce better academic outcomes in ADHD-diagnosed students? We found that stimulant drugs significantly improved impairment of episodic memory in ADHD-diagnosed undergraduate students. Nevertheless, we also found consistent academic deficits between ADHD students and their non-ADHD counterparts, regardless of whether or not they used stimulant medications. We reviewed the current literature on the behavioral effects of stimulants, to try to find an explanation for these conflicting phenomena. Across a variety of behavioral tasks, stimulants have been shown to reduce emotional reactions to frustration, improve the ability to detect errors, and increase effortful behavior. However, all of these effects would presumably enhance academic performance. On the other hand, the drugs were also found to promote "risky behavior" and to increase susceptibility to environmental distraction. Such negative effects, including the use of drugs to promote wakefulness for last minute study, might explain the lack of academic benefit in the "real world," despite their cognitive potential. Like many drugs, stimulants influence behavior in multiple ways, depending on the environmental contingencies. Depending on the circumstances, stimulants may, or may not, enhance cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colman (2022) · doi:10.1073/pnas · Cited by 4,370
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
Willcutt, E. G. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0135-8 · Cited by 2,160 · cited 1×
“In support of that interpretation, current best estimates for an ADHD diagnosis, of 5.9–7.1% in children and adolescents, and 5.0% in adults, represent 25% and 13.6% increases, respectively (Kessler et al., 2006; Willcutt, 2012; Getahun et al., 2013).”
BackgroundInfluentialMisuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815a56f1 · Cited by 824 · cited 2×
“Numerous surveys of college populations have reported an increase in stimulant prescriptions and a corresponding escalation of illicit use (Wilens et al., 2008; Advokat, 2010; Advokat and Vinci, 2012; Varga, 2012), with lifetime rates of diversion ranging from 5–29% (Wilens et al., 2008; Smith and…”
BackgroundA novel demonstration of enhanced memory associated with emotional arousal
Cahill, L., & McGaugh, J. L. (1995) · Consciousness and Cognition · doi:10.1006/ccog.1995.1048 · Cited by 616
Acute administration of d-amphetamine decreases impulsivity in healthy volunteers
de Wit, H. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00343-3 · Cited by 436 · cited 1×
“In fact, these drugs also reduce impulsivity in healthy adults (de Wit et al., 2002).”
BackgroundSwanson, J., Baler, R. D., & Volkow, N. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.160 · Cited by 252
Advokat, C. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.03.006 · Cited by 219 · cited 5×
“It is not surprising that the most reliable effect of stimulants in our studies, as well as that of others (Advokat, 2010; Advokat and Vinci, 2012), is to reduce impulsivity, since that is one of the reasons they are prescribed.”
BackgroundInfluentialSelf-citationRobbins, T. W., & Sahakian, B. J. (1979) · Neuropharmacology · doi:10.1016/0028-3908(79)90157-6 · Cited by 170 · cited 1×
“Results concerning risky behavior might be reinterpreted as evidence of stimulant-induced “inflexibility,” or “cognitive stereotopy,” which have been recognized for a long time (Robbins and Sahakian, 1979).”
BackgroundLangberg, J. M., & Becker, S. P. (2012) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-012-0117-8 · Cited by 129 · cited 1×
“The most recent review of long-term ADHD medication on academic outcomes in youth (Langberg and Becker, 2012) confirmed these earlier conclusions.”
Background
Cited by
Roberts, C. A., Jones, A., Sumnall, H., Gage, S. H., & Montgomery, C. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.07.002 · Cited by 78
Methylphenidate alters selective attention by amplifying salience
ter Huurne, N., Fallon, S. J., van Schouwenburg, M., van der Schaaf, M., Buitelaar, J., Jensen, O., & Cools, R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4059-y · Cited by 31
“This trend has instigated a worldwide debate on whether it is safe to use methylphenidate as a nonprescribed drug and to what extent cognition really is enhanced by methylphenidate (Advokat and Scheithauer 2013; Greely et al. 2008; Smith and Farah 2011).”
InfluentialRe: Is Adult Attention-Deficit Hyperactivity Disorder Being Overdiagnosed?
Katzman, M. A., Bilkey, T., Chokka, P. R., Fallu, A., & Klassen, L. J. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743715620143 · Cited by 17
“They suggest nonmedical benefit seeking of people on ADHD treatments.1 This contrasts with literature suggesting that stimulants do not enhance cognitive performance outside the treatment of ADHD.5 It is ridiculous to suggest that researchers are inflating prevalence rates to boost their funding for grants or that the…”
BackgroundInfluentialStimulants, cognition and ADHD
Baroni, A., & Castellanos, F. X. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.04.010 · Cited by 14
“Despite their reputation as ‘smart pills’ and their increasing non-medical and medical use [5,6], the documented cognitive and academic benefits of stimulants are surprisingly modest [7–10,11 ].”
BackgroundKassim, F. M. (2023) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2856 · Cited by 10
“Findings from rodents (Seamans et al., 1998), non‐human primates (Arnsten et al., 1994; Sawaguchi & Goldman‐ Rakic, 1991, 1994; Vijayraghavan et al., 2007; Williams & Goldmanrakic, 1995), and people with schizophrenia (Abi‐ Dargham, 2002; Okubo et al., 1997) and ADHD (Westerberg et al., 2004) have demonstrated that do…”
BackgroundInfluential
Metadata
- Authors
- Advokat, C., & Scheithauer, M.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 7
- Pages
- 82-82
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2054149386
- Cited by
- 66
- References
- 17
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers. https://app.cochat.ai/papers/10.3389/fnins.2013.00082
- The paper
- Advokat, C., & Scheithauer, M. (2013). Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2013.00082
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.